L. J. Prevo

Evolution of neoplastic cell lineages in Barrett oesophagus

Carissa A. Sanchez, Brian J. Reid, Michael T. Barrett, 1999, Nature Genetics.

Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue.

Carissa A. Sanchez, B. Reid, G. Longton, 2000, Journal of the National Cancer Institute.

High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues.

M. Barrett, B. Reid, P. Rabinovitch, 2002, BioTechniques.

Electron spin-echo spectroscopy at 95 GHz

Jan F. Schmidt, W. Wenckebach, R. Weber, 1989 .

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

P. Blount, B. Reid, P. Rabinovitch, 2001 .

Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.

A. Kristal, P. Blount, B. Reid, 2003, Journal of the National Cancer Institute.

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

Patricia L. Blount, A. Kristal, P. Blount, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Nonsteroidal Anti-inflammatory Drug Use , Body Mass Index , and Anthropometry in Relation to Genetic and Flow Cytometric Abnormalities in Barrett ’ s Esophagus 1

A. Kristal, P. Blount, B. Reid, 2002 .

p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.

Patricia L. Blount, D. Wong, P. Blount, 2001, Cancer research.

Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

Carissa A. Sanchez, Patricia L. Blount, P. Blount, 2001, American Journal of Gastroenterology.

Undergo Clonal Expansion in Barrett ' s Metaplastic Epithelium Lesions Are Common , Early Abnormalities thatINK 4 a p 16 Updated

Patricia L. Blount, D. Wong, P. Blount, 2001 .

p53-mutant clones and field effects in Barrett's esophagus.

B. Reid, P. Galipeau, C. Sanchez, 1999, Cancer research.

Original contributionPredictors of progression in Barrett’s esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression

P. Blount, B. Reid, P. Rabinovitch, 2001 .